The Effect Of Tafamidis Meglumine In Transthyretin Amyloid Polyneuropathy Patients
Clinical trial NCT04828993 · COMPLETED
Trial details
- NCT number
- NCT04828993
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-28
- Primary completion
- 2023-02-12
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.